Oseltamivir Phosphate Capsule
Product Images NDC 68180-676

7 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 68180-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (D28b6190 F009 485f 905e 63f7a22fb68c 01)

Image 1 (D28b6190 F009 485f 905e 63f7a22fb68c 01)
Chemical structure of oseltamivir phosphate, showing the molecular arrangement including the cyclohexene ring, ethyl ester group, amino group, and phosphate moiety.*
FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 296 1)

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 296 1)
Oseltamivir phosphate 75 mg capsules, oral dosage form, packaged in a white and gray box. The label prominently displays the product name Oseltamivir phosphate, strength 75 mg, capsule form, and indicates it is manufactured by Lupin Pharmaceuticals, Inc. The box design includes the labeler logo and relevant regulatory information.*
FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 299 1)

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 299 1)
Oseltamivir phosphate 30 mg capsule blister packaging with capsules visible through a clear plastic cover. The label shows dose strength and the capsules are contained in a strip format, labeled by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 241 1)

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 241 1)
Oseltamivir phosphate capsules in blister packaging from Lupin Pharmaceuticals, Inc. The image shows multiple capsules arranged in two cluster shapes on a white background. Each capsule contains oseltamivir phosphate as the active ingredient, available in strengths including 30 mg, 45 mg, and 75 mg.*
FDA Label Image

Image 4 (D28b6190 F009 485f 905e 63f7a22fb68c 02)

Image 4 (D28b6190 F009 485f 905e 63f7a22fb68c 02)
Packaging label for Oseltamivir Phosphate Capsules USP 30 mg by Lupin Pharmaceuticals, Inc. The carton displays the NDC 68180-675-11 and indicates the package contains 10 oral capsules. The label features a capsule illustration marked "30 mg" and information about storage conditions and prescription status.*
FDA Label Image

Image 7 (D28b6190 F009 485f 905e 63f7a22fb68c 03)

Image 7 (D28b6190 F009 485f 905e 63f7a22fb68c 03)
Packaging label for Oseltamivir Phosphate Capsules USP 45 mg by Lupin Pharmaceuticals, Inc. The label features the product name prominently with a dosage strength of 45 mg, indicating 10 capsules per package. The label includes the NDC number 68180-676-11, and states Rx only. The design incorporates a green and blue color scheme with an image of a capsule marked '45 mg LU.' Storage instructions and other regulatory text are also included.*
FDA Label Image

Image 10 (D28b6190 F009 485f 905e 63f7a22fb68c 04)

Image 10 (D28b6190 F009 485f 905e 63f7a22fb68c 04)
Box packaging label for Oseltamivir Phosphate Capsules USP 75 mg by Lupin Pharmaceuticals, Inc. The label includes the NDC 68180-677-11, with dosage strength prominently shown in red. The capsules are oral, come in a count of 10 per package, and the label indicates Rx only. Storage instructions and usual dosage advice are also noted on the box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.